Capricor
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.About CAPR
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine.
CEOLinda Marbán
CEOLinda Marbán
Employees160
Employees160
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1996
Founded1996
Employees160
Employees160
CAPR Key Statistics
Market cap306.30M
Market cap306.30M
Price-Earnings ratio-4.08
Price-Earnings ratio-4.08
Dividend yield—
Dividend yield—
Average volume1.12M
Average volume1.12M
High today$6.90
High today$6.90
Low today$6.46
Low today$6.46
Open price$6.62
Open price$6.62
Volume915.34K
Volume915.34K
52 Week high$23.40
52 Week high$23.40
52 Week low$5.68
52 Week low$5.68
CAPR News
Simply Wall St 6d
Is FDA Embrace of HOPE-3 Data Shaping the Investment Thesis for Capricor Therapeutics?In September 2025, Capricor Therapeutics announced a regulatory update after a Type A meeting with the FDA, detailing that the HOPE-3 trial would address concer...
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CAPR. This list is generated using Robinhood data, and it’s not a recommendation.